Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Brahmi

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Expert Review of Anticancer Therapy|December 31, 2025
An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcomaMargaux Dupont, Armelle Dufresne, Mehdi Brahmi, et al.
Surgical Oncology Clinics of North America|June 17, 2022
New Drug Approvals for Sarcoma in the Last 5 YearsPrapassorn Thirasastr, Mehdi Brahmi, Armelle Dufresne, et al.
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies targeting CD3 in oncology and hematology]Hélène Vanacker, Armelle Vinceneux, Emmanuelle Nicolas-Virelizier, et al.
Cancers|March 29, 2023
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and BeyondMina Fazel, Armelle Dufresne, Hélène Vanacker, et al.
BMC Cancer|September 2, 2014
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technologyArmelle Dufresne, Laurent Alberti, Mehdi Brahmi, et al.
Cancers|February 25, 2022
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and BeyondAxel de Bernardi, Armelle Dufresne, Florence Mishellany, et al.
Translational Gastroenterology and Hepatology|May 31, 2019
Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectivesMarie Laurent, Mehdi Brahmi, Armelle Dufresne, et al.
Plos One|October 8, 2015
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 PatientsMehdi Brahmi, Philippe Thiesse, Dominique Ranchere, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2024
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of ImmunotherapeuticsHélène Vanacker, Robert Connacher, Alexandra Meurgey, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Expert Review of Anticancer Therapy|December 31, 2025
An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcomaMargaux Dupont, Armelle Dufresne, Mehdi Brahmi, et al.
Surgical Oncology Clinics of North America|June 17, 2022
New Drug Approvals for Sarcoma in the Last 5 YearsPrapassorn Thirasastr, Mehdi Brahmi, Armelle Dufresne, et al.
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies targeting CD3 in oncology and hematology]Hélène Vanacker, Armelle Vinceneux, Emmanuelle Nicolas-Virelizier, et al.
Cancers|March 29, 2023
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and BeyondMina Fazel, Armelle Dufresne, Hélène Vanacker, et al.
BMC Cancer|September 2, 2014
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technologyArmelle Dufresne, Laurent Alberti, Mehdi Brahmi, et al.
Cancers|February 25, 2022
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and BeyondAxel de Bernardi, Armelle Dufresne, Florence Mishellany, et al.
Translational Gastroenterology and Hepatology|May 31, 2019
Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectivesMarie Laurent, Mehdi Brahmi, Armelle Dufresne, et al.
Plos One|October 8, 2015
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 PatientsMehdi Brahmi, Philippe Thiesse, Dominique Ranchere, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2024
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of ImmunotherapeuticsHélène Vanacker, Robert Connacher, Alexandra Meurgey, et al.
Pageof 8